All members have the option of attending our various HTC-centric events which include:
Date: Tuesday, August 8, 2023
Time: 1:00pm – 2:00pm ET
TITLE:
HTC preparation for ROCTAVIAN ™ (valoctocogene roxaparvovec-rvox)
OBJECTIVE:
Learn about eligibility testing, ordering, storing, handling and administering ROCTAVIAN
TARGET AUDIENCE:
HTC staff interested in learning about ROCTAVIAN’s clinical and logistical requirements
SPEAKER:
Henry Mead PhD, MBA, MPA
Senior Director, BioMarin Hemophilia North America Medical Affairs
Henry Mead has worked in medical affairs for over two decades in North America and globally. Over the last 15 years it has been his privilege to work closely with hemophilia researchers, clinical investigators, patient advocates, and hemophilia nurses. His experience includes leading medical affairs team’s ensuring they adhere to the principles of credible, accurate and balanced scientific dissemination of data to external customers. Additionally, identifying, vetting, and supporting investigator-initiated research and publishing relevant findings has been an important component of knowledge transfer activities.
